Novartis unveiled promising performance targets at its 2020 CMD. Besides striving for healthy top-line growth – driven by diverse innovations, the group also plans to improve operating margins – even after having achieved improvements over the years. More importantly, the shareholder rewards focus again come to the fore as the group unveiled a share buy-back programme.
Overall, these were much needed measures – considering the disappointing share price performance in recent years, and could wel ....
26 Nov 2020
Takeaways from 2020 Capital Markets Day
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Takeaways from 2020 Capital Markets Day
Novartis unveiled promising performance targets at its 2020 CMD. Besides striving for healthy top-line growth – driven by diverse innovations, the group also plans to improve operating margins – even after having achieved improvements over the years. More importantly, the shareholder rewards focus again come to the fore as the group unveiled a share buy-back programme.
Overall, these were much needed measures – considering the disappointing share price performance in recent years, and could wel ....